Company Description

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona.

Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Picard Medical, Inc.

Country	United States
Founded	1981
IPO Date	Aug 29, 2025
Industry	Medical Devices
Sector	Healthcare
Employees	75
CEO	Yuncai Fang

Contact Details

Address: 1992 East Silverlake Road Tucson, Arizona 85713 United States
Phone	520 545 1234
Website	picardmedical.com

Stock Details

Ticker Symbol	PMI
Exchange	NYSEAMERICAN
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$4.00
CIK Code	2030617
CUSIP Number	71953R207
ISIN Number	US71953R2076
SIC Code	3841

Key Executives

Name	Position
Dr. Yuncai Fang Ph.D.	Interim Chief Executive Officer and Chairman of the Board
Matthew Schuster	Chief Operating Officer
Georgina Smith	Chief Accounting Officer
Dr. Frank Tinker Ph.D.	Chief Technology Officer of SynCardia Systems, LLC

Latest SEC Filings

Date	Type	Title
Aug 7, 2026	SCHEDULE 13G/A	Filing
Jul 27, 2026	8-K	Current Report
Jul 22, 2026	8-K	Current Report
Jul 21, 2026	8-K	Current Report
Jul 16, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jul 13, 2026	8-K/A	[Amend] Current report
Jul 8, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jul 7, 2026	8-K/A	[Amend] Current report
Jul 2, 2026	425	Filing
Jul 2, 2026	8-K	Current Report

View All SEC Filings